|
2023-05-09 |
2023-05-05 |
K
Kauf
|
BVF PARTNERS L P/IL
Large shareholder
|
86.341
0,00
0 USD
|
86.341
|
0,00
|
0 USD
|
|
|
2023-05-09 |
2023-05-05 |
K
Kauf
|
BVF PARTNERS L P/IL
Large shareholder
|
837.146
0,00
0 USD
|
837.146
|
0,00
|
0 USD
|
|
|
2023-05-09 |
2023-05-05 |
K
Kauf
|
BVF PARTNERS L P/IL
Large shareholder
|
1.055.445
0,00
0 USD
|
1.055.445
|
0,00
|
0 USD
|
|
|
2022-11-23 |
2022-11-23 |
K
Kauf
|
Perrin Steven
President
Geschäftsführender Verwaltungsratsmitglied
|
1.000
+inf%
2,60
2.597 USD
|
1.000
+inf%
|
2,60
|
2.597 USD
|
|
|
2021-12-21 |
2021-12-20 |
K
Kauf
|
Gros David-Alexandre C
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
2.000
+28.6%
4,48
8.960 USD
|
2.000
+28.6%
|
4,48
|
8.960 USD
|
|
|
2021-06-14 |
2021-06-11 |
K
Kauf
|
Little Paul Sean
CHIEF FINANCIAL OFFICER
Führungsperson
|
10.000
+inf%
8,87
88.700 USD
|
10.000
+inf%
|
8,87
|
88.700 USD
|
|
|
2021-06-10 |
2021-06-09 |
K
Kauf
|
Gros David-Alexandre C
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
3.000
+inf%
8,01
24.030 USD
|
3.000
+inf%
|
8,01
|
24.030 USD
|
|
|
2020-12-04 |
2020-12-02 |
V
Verkauf
|
OrbiMed Israel GP Ltd.
Large shareholder
|
103.200
-58.4%
21,60
2.229.120 USD
|
103.200
-58.4%
|
21,60
|
2.229.120 USD
|
|
|
2020-11-06 |
2020-10-30 |
K
Kauf
|
Logos Global Management LP
Large shareholder
|
9.098
+4.2%
25,55
232.460 USD
|
9.098
+4.2%
|
25,55
|
232.460 USD
|
|
|
2020-11-06 |
2020-10-30 |
K
Kauf
|
Logos Global Management LP
Large shareholder
|
15.000
+7.5%
26,17
392.610 USD
|
15.000
+7.5%
|
26,17
|
392.610 USD
|
|
|
2020-11-06 |
2020-10-30 |
V
Verkauf
|
Logos Global Management LP
Large shareholder
|
27
-0.0%
27,02
730 USD
|
27
-0.0%
|
27,02
|
730 USD
|
|
|
2020-11-06 |
2020-10-30 |
K
Kauf
|
Logos Global Management LP
Large shareholder
|
12.942
+6.9%
25,88
334.926 USD
|
12.942
+6.9%
|
25,88
|
334.926 USD
|
|
|
2020-11-06 |
2020-10-30 |
V
Verkauf
|
Logos Global Management LP
Large shareholder
|
12.942
-6.5%
26,64
344.829 USD
|
12.942
-6.5%
|
26,64
|
344.829 USD
|
|
|
2020-11-06 |
2020-10-30 |
K
Kauf
|
Logos Global Management LP
Large shareholder
|
15.000
+8.1%
26,48
397.236 USD
|
15.000
+8.1%
|
26,48
|
397.236 USD
|
|
|
2020-11-06 |
2020-10-30 |
K
Kauf
|
Logos Global Management LP
Large shareholder
|
4.000
+2.2%
25,97
103.892 USD
|
4.000
+2.2%
|
25,97
|
103.892 USD
|
|
|
2020-11-06 |
2020-10-30 |
K
Kauf
|
Logos Global Management LP
Large shareholder
|
31.000
+20.7%
24,53
760.427 USD
|
31.000
+20.7%
|
24,53
|
760.427 USD
|
|
|
2020-11-06 |
2020-10-30 |
K
Kauf
|
Logos Global Management LP
Large shareholder
|
5.000
+3.4%
24,03
120.163 USD
|
5.000
+3.4%
|
24,03
|
120.163 USD
|
|
|
2019-05-22 |
2019-05-21 |
V
Verkauf
|
FLESHER GREGORY J.
Chief Executive Officer
|
2.937
-1.8%
1,91
5.614 USD
|
2.937
-1.8%
|
1,91
|
5.614 USD
|
|
|
2019-05-22 |
2019-05-21 |
V
Verkauf
|
Kuwahara Jon
See Remarks
|
1.058
-15.0%
1,91
2.022 USD
|
1.058
-15.0%
|
1,91
|
2.022 USD
|
|
|
2019-05-22 |
2019-05-21 |
V
Verkauf
|
TURKEL CATHERINE C.
President
|
1.914
-2.1%
1,91
3.658 USD
|
1.914
-2.1%
|
1,91
|
3.658 USD
|
|
|
2019-05-22 |
2019-05-20 |
V
Verkauf
|
FLESHER GREGORY J.
Chief Executive Officer
|
11.701
-6.8%
1,96
22.953 USD
|
11.701
-6.8%
|
1,96
|
22.953 USD
|
|
|
2019-05-22 |
2019-05-20 |
V
Verkauf
|
Kuwahara Jon
See Remarks
|
4.218
-37.5%
1,96
8.274 USD
|
4.218
-37.5%
|
1,96
|
8.274 USD
|
|
|
2019-05-22 |
2019-05-20 |
V
Verkauf
|
TURKEL CATHERINE C.
President
|
7.623
-7.8%
1,96
14.953 USD
|
7.623
-7.8%
|
1,96
|
14.953 USD
|
|
|
2019-05-06 |
2019-05-02 |
K
Kauf
|
Chimovits Erez
|
646.204
+25.5%
3,10
2.003.232 USD
|
646.204
+25.5%
|
3,10
|
2.003.232 USD
|
|
|
2019-05-06 |
2019-05-02 |
K
Kauf
|
OrbiMed Israel GP Ltd.
Large shareholder
|
646.204
+25.5%
3,10
2.003.232 USD
|
646.204
+25.5%
|
3,10
|
2.003.232 USD
|
|
|
2019-05-02 |
2019-04-30 |
V
Verkauf
|
LIFESCI INDEX PARTNERS LLC
Large shareholder
|
200
-0.0%
2,70
540 USD
|
200
-0.0%
|
2,70
|
540 USD
|
|
|
2018-09-13 |
2018-09-12 |
K
Kauf
|
TURKEL CATHERINE C.
President
Führungsperson
|
16.632
+27.0%
5,02
83.476 USD
|
16.632
+27.0%
|
5,02
|
83.476 USD
|
|
|
2018-09-13 |
2018-09-11 |
K
Kauf
|
TURKEL CATHERINE C.
President
Führungsperson
|
17.048
+38.3%
4,56
77.671 USD
|
17.048
+38.3%
|
4,56
|
77.671 USD
|
|
|
2018-09-07 |
2018-09-05 |
K
Kauf
|
TURKEL CATHERINE C.
President
Führungsperson
|
805
+inf%
3,97
3.193 USD
|
805
+inf%
|
3,97
|
3.193 USD
|
|
|
2017-05-11 |
2017-05-10 |
K
Kauf
|
FLESHER GREGORY J.
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
58.959
+103.6%
9,99
589.000 USD
|
58.959
+103.6%
|
9,99
|
589.000 USD
|
|
|
2017-05-11 |
2017-05-10 |
K
Kauf
|
TURKEL CATHERINE C.
Chief Development Officer
Führungsperson
|
11.111
+82.9%
9,99
110.999 USD
|
11.111
+82.9%
|
9,99
|
110.999 USD
|
|
|
2017-05-11 |
2017-05-10 |
K
Kauf
|
OCAMPO CHRISTINE
See Remarks
Führungsperson
|
10.010
+86.4%
9,99
100.000 USD
|
10.010
+86.4%
|
9,99
|
100.000 USD
|
|
|
2016-03-15 |
2016-03-15 |
K
Kauf
|
Buckley Stephen Jr.
Nicht geschäftsführender Verwaltungsratsmitglied
|
8.000
+266.7%
5,74
45.920 USD
|
8.000
+266.7%
|
5,74
|
45.920 USD
|
|
|
2015-11-12 |
2015-11-11 |
K
Kauf
|
Buckley Stephen Jr.
Nicht geschäftsführender Verwaltungsratsmitglied
|
3.000
+inf%
11,25
33.750 USD
|
3.000
+inf%
|
11,25
|
33.750 USD
|
|
|
2015-09-22 |
2015-09-21 |
GV
Geplanter Verkauf
|
McBride John S.
Chief Operating Officer
Führungsperson
|
13.500
-100.0%
14,01
189.135 USD
|
13.500
-100.0%
|
14,01
|
189.135 USD
|
|
|
2015-07-30 |
2015-07-29 |
GV
Geplanter Verkauf
|
Morrison Jodie Pope
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
564
-2.8%
13,70
7.727 USD
|
564
-2.8%
|
13,70
|
7.727 USD
|
|
|
2015-07-30 |
2015-07-28 |
GV
Geplanter Verkauf
|
Morrison Jodie Pope
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
12.000
-38.0%
13,70
164.400 USD
|
12.000
-38.0%
|
13,70
|
164.400 USD
|
|
|
2015-07-17 |
2015-07-15 |
V
Verkauf
|
Novartis Bioventures Ltd
Large shareholder
|
3.566
-0.1%
14,26
50.844 USD
|
3.566
-0.1%
|
14,26
|
50.844 USD
|
|
|
2015-07-15 |
2015-07-14 |
V
Verkauf
|
Novartis Bioventures Ltd
Large shareholder
|
27.861
-0.6%
14,41
401.477 USD
|
27.861
-0.6%
|
14,41
|
401.477 USD
|
|
|
2015-07-15 |
2015-07-13 |
V
Verkauf
|
Novartis Bioventures Ltd
Large shareholder
|
20.611
-0.5%
14,20
292.717 USD
|
20.611
-0.5%
|
14,20
|
292.717 USD
|
|
|
2015-06-30 |
2015-06-29 |
GV
Geplanter Verkauf
|
Morrison Jodie Pope
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
8.000
-45.6%
13,70
109.600 USD
|
8.000
-45.6%
|
13,70
|
109.600 USD
|
|
|
2015-06-30 |
2015-06-26 |
GV
Geplanter Verkauf
|
Morrison Jodie Pope
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
8.000
-45.6%
13,83
110.640 USD
|
8.000
-45.6%
|
13,83
|
110.640 USD
|
|
|
2015-06-24 |
2015-06-24 |
GV
Geplanter Verkauf
|
McBride John S.
Chief Operating Officer
Führungsperson
|
300
-100.0%
14,20
4.260 USD
|
300
-100.0%
|
14,20
|
4.260 USD
|
|
|
2015-06-24 |
2015-06-23 |
GV
Geplanter Verkauf
|
McBride John S.
Chief Operating Officer
Führungsperson
|
6.700
-100.0%
14,00
93.800 USD
|
6.700
-100.0%
|
14,00
|
93.800 USD
|
|
|
2015-06-24 |
2015-06-22 |
GV
Geplanter Verkauf
|
McBride John S.
Chief Operating Officer
Führungsperson
|
2.000
-100.0%
14,02
28.040 USD
|
2.000
-100.0%
|
14,02
|
28.040 USD
|
|
|
2015-06-18 |
2015-06-16 |
V
Verkauf
|
Novartis Bioventures Ltd
Large shareholder
|
1.120
-0.0%
14,27
15.982 USD
|
1.120
-0.0%
|
14,27
|
15.982 USD
|
|
|
2015-06-16 |
2015-06-12 |
V
Verkauf
|
Novartis Bioventures Ltd
Large shareholder
|
5.919
-0.1%
14,20
84.050 USD
|
5.919
-0.1%
|
14,20
|
84.050 USD
|
|
|
2015-06-12 |
2015-06-11 |
V
Verkauf
|
Novartis Bioventures Ltd
Large shareholder
|
27.875
-0.6%
14,20
395.825 USD
|
27.875
-0.6%
|
14,20
|
395.825 USD
|
|
|
2015-03-20 |
2015-03-19 |
V
Verkauf
|
Novartis Bioventures Ltd
Large shareholder
|
46.141
-1.0%
14,50
669.045 USD
|
46.141
-1.0%
|
14,50
|
669.045 USD
|
|
|
2015-03-20 |
2015-03-18 |
V
Verkauf
|
Novartis Bioventures Ltd
Large shareholder
|
3.000
-0.1%
14,50
43.500 USD
|
3.000
-0.1%
|
14,50
|
43.500 USD
|
|
|
2014-09-24 |
2014-09-22 |
K
Kauf
|
Apple Tree Partners II - Annex, L.P.
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
237.500
+7.1%
15,00
3.562.500 USD
|
237.500
+7.1%
|
15,00
|
3.562.500 USD
|
|
|
2014-09-24 |
2014-09-22 |
K
Kauf
|
Novartis Bioventures Ltd
Large shareholder
|
325.000
+7.5%
15,00
4.875.000 USD
|
325.000
+7.5%
|
15,00
|
4.875.000 USD
|
|
|
2014-09-24 |
2014-09-22 |
K
Kauf
|
Harrison Seth Loring
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
362.500
+4.8%
15,00
5.437.500 USD
|
362.500
+4.8%
|
15,00
|
5.437.500 USD
|
|
|
2014-09-24 |
2014-09-22 |
K
Kauf
|
Satter Muneer A
Large shareholder
|
150.000
+9.2%
15,00
2.250.000 USD
|
150.000
+9.2%
|
15,00
|
2.250.000 USD
|
|
|
2015-06-16 |
2014-06-15 |
V
Verkauf
|
Novartis Bioventures Ltd
Large shareholder
|
14.777
-0.3%
14,20
209.833 USD
|
14.777
-0.3%
|
14,20
|
209.833 USD
|
|
